Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-16

FDA Approved: PLERIXAFOR — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic version of plerixafor (Mozobil) for mobilizing hematopoietic stem cells in adults with non-Hodgkin lymphoma or multiple myeloma who are p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

ORIG AP for PLERIXAFOR (PLERIXAFOR)